Saliwell Ltd.
Saliwell has developed a technological solution for the treatment of xerostomia. The patented SaliPen device treats mouth by electro-stimulation of low-intensity that is not felt by the patient. By triggering salivary glands to produce more saliva, the dry mouth sensation declines. As opposed to currently available treatments, Saliwell’s solution is characterized by long-lasting and robust beneficial effects, no side effects and low costs.
SaliPen is worn typically for only a few minutes every day. It has two flexible arms with electrodes that are placed on the inner gums of the lower wisdom teeth, underneath the tongue. The rest of the device stays outside the mouth.
A worldwide post marketing Phase IV trial in 14 clinical centers showed significant improvement in oral wetness over an 11 month period. FDA (USA), CE (Europe) and TGA (Australia) have approved the SaliPen device.
SaliPen is worn typically for only a few minutes every day. It has two flexible arms with electrodes that are placed on the inner gums of the lower wisdom teeth, underneath the tongue. The rest of the device stays outside the mouth.
A worldwide post marketing Phase IV trial in 14 clinical centers showed significant improvement in oral wetness over an 11 month period. FDA (USA), CE (Europe) and TGA (Australia) have approved the SaliPen device.